A double blind study of dexamethasone for the treatment of H5N1 Avian Influenza

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN07092892

Enrollment

Registered

2005-07-22

Start date

2005-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avian Influenza Infections and Infestations Avian influenza

Interventions

Dexamethasone

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with confirmed TaqMan Influenza A positive, or H5N1 PCR 2. Patients with history of clear close exposure to sick poultry, Chest X-Ray changes consistent with H5N1, low white count and strong clinical suspicion of H5N1 infection

Exclusion criteria

Exclusion criteria: No consent

Design outcomes

Primary

Measure	Time frame
Mortality	—

Secondary

Measure	Time frame
1. Duration of ventilation 2. Duration of supplemental oxygen 3. Duration of hospitalisation 4. Viral load in clinical specimens 5. Cytokine levels 6. Adverse effects	—

Countries

Viet Nam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026